Lv0
0 积分 2024-09-14 加入
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma
9天前
已完结
Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis
9天前
已完结
CD70-targeted cancer theranostics: Progress and challenges
1个月前
已完结
Hemophagocytic lymphohistiocytosis: An update on pathogenesis, diagnosis, and therapy
2个月前
已完结
Treatment outcomes between cyclosporin and chemotherapy in adult subcutaneous panniculitis-like T-cell lymphoma: a report from nation-wide Thai lymphoma study group registry
3个月前
已完结
Immunosuppressive therapy as first‐line and relapse treatment in paediatric subcutaneous panniculitis‐like T‐cell lymphoma
3个月前
已完结
CD180 as a Robust Immunophenotypic Marker for Differentiating Lymphoplasmacytic Lymphoma/ Waldenström Macroglobulinemia from Marginal Zone Lymphoma
4个月前
已完结
Subcutaneous Panniculitis-like T-Cell Lymphoma
4个月前
已完结
Current and upcoming treatment approaches to uncommon subtypes of PTCL (EATL/MEITL, SPTCL, HSTCL)
4个月前
已完结
The potential of methioninase for cancer treatment
6个月前
已完结
皖公网安备34019202002308
